Labshake search
Citations for Bio X Cell :
251 - 300 of 745 citations for Calcium calmodulin Dependent 3' 5' Cyclic Nucleotide Phosphodiesterase 1C PDE1C Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... All cells were blocked with Fcγ blocking antibody (24G2, BioXcell) and incubated with fixable cell viability dye eF780 (Thermo Fisher or BD ...
-
bioRxiv - Microbiology 2022Quote: ... IP administration of anti-CD4 monoclonal antibody (clone: GK1.5; BioXCell) was used to deplete mice of CD4+ T cells ...
-
bioRxiv - Immunology 2022Quote: ... Anti- NKG2D antibody (10 μg/mL, Bio X Cell #BE0334) or rat IgG1 isotype control antibody (10 μg/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... agonist antibody or rat IgG2a isotype control (clone 2A3; BioXCell) was administered intraperitoneally (IP ...
-
bioRxiv - Immunology 2020Quote: ... InvivoMab anti-mouse IFNγ antibody was used (clone XMG1.2, BioXCell). 500 μg blocking antibody was injected i.p ...
-
bioRxiv - Microbiology 2021Quote: ... or an IgG1 isotype control antibody (clone HRPN; BioXCell, USA) one day prior to infection (75 ...
-
bioRxiv - Microbiology 2021Quote: ... or isotype IgG2a isotype control antibody (clone 2A3; BioXCell, USA) i.p ...
-
bioRxiv - Immunology 2019Quote: ... 200 µg of antibodies (anti-mCD8α clone 53-6.72, BioXCell or Rat IgG2a Isotype control ...
-
bioRxiv - Cancer Biology 2019Quote: ... Isotype control antibody (Clone: 2A3, BioXcell, West Lebanon, NH, USA) and αPD-1 antibody (Clone ...
-
bioRxiv - Developmental Biology 2020Quote: ... or rat monoclonal anti-mouse Ly6G antibody (clone 1A8, BioXCell) via intraperitoneal injection ...
-
bioRxiv - Microbiology 2019Quote: ... or rat IgG2b isotype control antibody (clone LTF-2, BioXCell) every other day ...
-
bioRxiv - Immunology 2020Quote: ... InVivoMab anti-mouse PD-L1 antibody (clone 10F.9G2, BioXCell), Stattic (MedChem Express) ...
-
bioRxiv - Immunology 2021Quote: ... and CD4 depleting antibody (clone GK1.5, BioXCell, cat. BP0003-1) were administered either in combination or as single agents at 200ug/antibody/mouse every third day starting one week prior to doxycycline diet addition for seven total doses.
-
bioRxiv - Immunology 2021Quote: ... PD-1 blocking antibody (clone 29F.1A12, BioXCell, cat. BP0273) and CTLA-4 blocking antibody (clone 9D9 ...
-
bioRxiv - Immunology 2021Quote: ... CD8 depleting antibody (clone 53-6.7, BioXCell, cat. BP0004-1) and CD4 depleting antibody (clone GK1.5 ...
-
bioRxiv - Immunology 2021Quote: ... or 200 µg of isotype control antibody (Rat IgG2a, BioXcell) two times prior and four times after i.t ...
-
bioRxiv - Neuroscience 2021Quote: ... and isotype control (rat IgG2a) antibodies were purchased from BioXcell. Mice were treated with a combination of 500 μg anti-LFA-1 and 500 μg anti-VLA-4 ...
-
bioRxiv - Immunology 2022Quote: ... 200 μg of antibody clone JAMA-147 (Bio X Cell) was injected intraperitoneally every 3 days starting at day 3 post tumour injection ...
-
bioRxiv - Cancer Biology 2022Quote: ... mice were treated with anti-CD8+ antibody [2.43 (BE0061, BioXcell), while controls were treated with 200 µg/mouse IgG [rat IgG2b (BE0090 ...
-
bioRxiv - Immunology 2022Quote: ... 200 μg of antibody clone M5/49.4.1 (Bio X Cell) was injected intraperitoneally at days -2 ...
-
bioRxiv - Immunology 2022Quote: ... injection of 500 μg anti-Ly6G/Ly6C antibody (Gr1, BioXCell) 24 h prior to infection as described previously (71) ...
-
bioRxiv - Immunology 2022Quote: ... and 0.5 mg OX40 agonist antibody (clone OX-86, BioxCell) or anti Horseradish peroxidase IgG1 Control (clone HRPN ...
-
bioRxiv - Cancer Biology 2022Quote: ... Purified anti-mouse PD1 antibody (BioXcell #BE0033-2; clone J43) was used for the in-vivo anti-PD1 blockade experiments ...
-
bioRxiv - Immunology 2023Quote: ... After Fc blocking using CD16/32 antibody (2.4 G2, BioXcell), cells were stained with fluorescent conjugated antibodies (Table S5 ...
-
bioRxiv - Microbiology 2022Quote: ... or anti-CD8 (116-13.1, Lyt2.1) antibody (BioxCell, CAT#BE0118). Each mouse received 200 μg of GK1.5 ...
-
bioRxiv - Cancer Biology 2023Quote: ... InVivoMAb anti-mouse CD22 antibody (Bio X Cell, cat# BE0011) was added for the final concentration of 5 μg/ml ...
-
bioRxiv - Immunology 2023Quote: ... IgG2a isotype control-matched antibody was purchased from BioXCell (#BE0085).
-
bioRxiv - Immunology 2023Quote: Blocking of unspecific antibody binding was achieved with 2.4G2 (BioXCell) and dead cells were stained using the Zombie NIR™ Fixable Viability Kit (Biolegend) ...
-
bioRxiv - Cancer Biology 2023Quote: ... or neutralizing antibody against CD8 (clone 53-5.8, BioXCell, BE0223) on days -3 ...
-
bioRxiv - Cancer Biology 2023Quote: ... monoclonal antibodies against murine PD-1 were purchased from BioXcell and given as intraperitoneal loading dose on first day of administration and every 3-4 d thereafter to wildtype C57Bl/6 mice bearing intracranial cortical GL261 or K-luc tumors.
-
bioRxiv - Immunology 2023Quote: ... Mouse anti-PD1 antibody was purchased from Bio X Cell. Cal12T cells were obtained from Horizon Discovery Ltd (Cambridge ...
-
bioRxiv - Immunology 2023Quote: ... All cells were blocked with Fcγ blocking antibody (24G2, BioXcell) and incubated with fixable cell viability dye eF780 (Thermo Fisher or BD ...
-
bioRxiv - Immunology 2023Quote: ... and their corresponding isotype control antibodies were purchased from BioXcell. The monoclonal antibody against 2W:I-Ab (clone ...
-
bioRxiv - Immunology 2023Quote: ... Ter119+ cells using Rat anti-mouse antibodies (BioXcell, NH, USA) and Dynabeads™ sheep anti-rat IgG beads (Invitrogen ...
-
bioRxiv - Cancer Biology 2023Quote: ... injected with an αIFNAR-1 antibody (200 μg; MAR15A3, BioXcell) twice per week ...
-
bioRxiv - Cancer Biology 2023Quote: ... or anti-CD8α depleting antibody (clone 2.43, Bio X cell) at day 0 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-mouse CD8β antibody (BioXCell, clone 53-5.8, BE0223), all diluted in InVivoPure pH 7.0 Dilution Buffer (BioXCell ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-mouse PD-L1 antibody (BioXCell, clone 10F.9G2, BE0101), and anti-mouse CD8β antibody (BioXCell ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-mouse PD-1 antibody (BioXCell, clone RMP1-14, BE0146), anti-mouse PD-L1 antibody (BioXCell ...
-
bioRxiv - Bioengineering 2023Quote: ... or its IgG2c isotype control antibody (BioXcell, clone DV5-1). Two days later ...
-
bioRxiv - Immunology 2023Quote: All Antibodies for in vivo treatments were purchased from BioXCell or Leinco ...
-
bioRxiv - Cancer Biology 2023Quote: ... or 100 μg αNK1.1 antibody (Clone PK136; BioXCell; Cat #BE0036) into each MC38 tumor-bearing mouse on Day 1 ...
-
bioRxiv - Immunology 2023Quote: ... 400 μg CD4 depletion antibody (Clone GK1.5, BioXCell, BE0003-1) in 200 μl PBS was injected intraperitoneally at day −2 and day −1 prior to tumor inoculation ...
-
bioRxiv - Genomics 2024Quote: ... CD11b (ITGAM) neutralizing antibody (Cat# BE0007, Bio X Cell, USA) was injected intraperitoneally at a dose of 100 μg per mouse for 2 consecutive days and 1 hour prior to LPS modelling ...
-
bioRxiv - Genetics 2024Quote: ... or anti-human PD1 antibody (BioXCell # BE0188, 10 μg/ml) was added during co-culture with EGFR CAR-T for blocking/neutralization.
-
bioRxiv - Immunology 2024Quote: ... or 10mg/kg anti-PD-1 antibody (BioXCell; cat#:BE0146) IP ...
-
bioRxiv - Immunology 2024Quote: ... or 10μg/mL human IgG4 isotype control antibody (BioXCell CP147) prior to co-culture with target cells ...
-
bioRxiv - Immunology 2024Quote: ... injected with anti-NK1.1 antibody (500 μg, clone PK136, BioXcell) on day 3 after tumor inoculation and then were maintained with 250 μg of anti-NK1.1 antibody every 3 days to deplete NK cells ...
-
bioRxiv - Immunology 2024Quote: ... Anti-mouse IL-2 antibody (BE0043) was purchased from Bioxcell and recombinant mouse IL-2 (carrier free ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...